Another chromosomal assignment for a simian virus 40 integration site in human cells by Kucherlapati,  R. et al.
Proc. Natl. Acad. Sci. USA
Vol. 75, No. 9, pp. 4460-4464, September 1978
Genetics
Another chromosomal assignment for a simian virus 40 integration
site in human cells
(transformed cells/cell hybrids/DNA blotting technique/viral integration)
RAJU KUCHERLAPATI*, S. P. HWANG*, N. SHIMIZUt, J. K. MCDOUGALLt, AND M. R. BOTCHANt
* Department of Biochemical Sciences, Princeton University, Princeton, New Jersey 08540 t Department of Cellular and Developmental Biology, University of
Arizona, Tucson, Arizona 85721; and t Cold Spring Harbor Laboratories, Cold Spring Harbor, New York 11724
Communicated by Frank H. Ruddle, May 26,1978
ABSTRACT Somatic cell h brids derived from fusion of
GM637, a human cell line transormed by simian virus 40, and
mouse B82 cells were examined for simian virus 40 T antigen,
V antigen, and viral DNA. All hybrid cell lines that contained
viral DNA were T-antigen positive. Cells that did not have viral
DNA were T-antigen negative. We determined that there is a
single viral insertion in these hybrid cells. Correlation of T-
antigen expression and viral DNA with the partial complements
of the human genome retained in the hybrids showed that the
inserted viral genome is in human chomosome 8. The integrated
viral DNA is stable; free viral DNA found in GM637 does not
insert at other potential sites in the human genome.
Simian virus 40 (SV40), a papovavirus, grows in African green
monkey cells and transforms human and a number of rodent
cells. The viral DNA persists in the transformed cells, and
continued viral gene expression is necessary to maintain the
transformed state (1-9). At least part of the integrated viral
DNA is usually present as an intact genome, because functional
virus particles can be obtained by fusion of the transformed cells
with permissive cells (10). The features of viral integration sites
are of interest because of possible interactions between inte-
grated viral DNA and adjacent host sequences. Furthermore,
the structure of viral insertions may reveal something about the
mechanisms of somatic recombination. Two different ap-
proaches have been traditionally used to study this problem.
On the one hand somatic cell genetic techniques have been
employed to determine the specificity of SV40 viral insertion
at the chromosomal level, while nucleic acid hybridization
techniques have been used to probe the structure of the inte-
grated viral DNA. Although these approaches are directed
toward understanding the same phenomena, the use of different
levels of study dictates that the data obtained by one approach
may not be relevant to the data obtained from the other.
Cells from human SV4O-transformed lines have been used
in fusions with mouse cells and hybrids have been tested for
expression of viral antigens. In early experiments of this type,
Weiss was unable to correlate loss of T antigen (T-ag) with the
loss of any specific human chromosome and concluded that the
virus might integrate at more than one site (11). Croce and
colleagues (12-18) have performed similar experiments with
three different transformed human lines. They correlated T-ag
expression with human chromosome 7 in two cases and chro-
mosome 17 in another. Biochemical studies directed toward the
question of specificity of viral integration have, in general,
focused on nonpermissive transformed host cells. This is due
to the fact that the induction of viral replication found in a
transformed semipermissive host such as human cells obscured
the detection of integrated copies. Botchan et al. (19) and
Ketner and Kelly (20) have used site-specific restriction en-
zymes to define (i) the points on the viral chromosome involved
in attachment to cellular DNA and (ii) the proximal chromo-
somal sequences with respect to these restriction sites. Both
groups have concluded that SV40 viral insertion into rodent
chromosomes cannot be mediated by a simple site-specific re-
combination event.
In this report we present the results of experiments that have
utilized a combination of genetic and biochemical approaches
to determine the chromosome site of integration of SV40 in a
human cell line that has not heretofore been studied. Hybrid
cell lines were obtained between B82, a murine cell line defi-
cient in thymidine kinase (TK), and GM637, a human fibroblast
cell line transformed with SV40. The hybrids were analyzed
for SV40 T-ag, V antigen (V-ag), and integrated viral DNA. In
every T-ag positive hybrid cell line only one inserted viral DNA
sequence could be detected. Detailed chromosome and isozyme
analysis allowed us to infer that this SV40 genome is integrated
into human chromosome 8. While more independent trans-
formed cell lines will have to be examined, it now seems quite
clear, despite previous claims to the contrary (12-18), that SV40
insertion into human DNA is not chromosome specific.
MATERIALS AND METHODS
Cells. GM637 cells were derived by SV40 transformation of
skin fibroblasts from an apparently normal woman. They were
obtained from A. Greene, Institute for Medical Research,
Camden, NJ. Though these were isolated as a mass population,
they are probably clonal in origin because of the presence of
common marker chromosomes in all cells (data not shown).
Mouse B82 cells were also obtained from the same source. Cells
were maintained in Dulbecco's modified Eagle's medium
(DMEM) (GIBCO) supplemented with penicillin and strepto-
mycin and 10% fetal bovine serum (Flow Laboratories) and 20
,uM glutamine (GIBCO).
Cell Fusion. GM637 in passage 64 and B82 at 2 X 106 cells
each were plated in a T-25 flask and incubated at 370 overnight.
Fusions were performed by a method described by Davidson
et al. (21). Briefly, the medium was completely removed and
3 ml of 50% (wt/vol) polyethylene glycol, molecular weight
1000, was added to the cell sheet. After a 2-min exposure the
polyethylene glycol was removed and the cell sheet was rapidly
washed three times with fresh medium. The cells were trypsi-
nized 24 hr later and plated into T-25 flasks containing DMEM
supplemented with 0.1 mM hypoxanthine/0.4 ,AM aminop-
terin/16 ,M thymidine (HAT) and 10 ,uM ouabain. Colonies
appeared in 2-3 weeks and were isolated by the use of stainless
steel cloning cylinders. Cell lines were maintained in
DMEM/HAT.
Subcloning and Back Selection. Secondary cell lines were
derived by plating approximately 100 cells/T-25 flask. Well-
Abbreviations: SV40, simian virus 40; T-ag, T antigen; V-ag, V antigen;
TK, thymidine kinase; DMEM, Dulbecco's modified Eagle's medium;
HAT, hypoxanthine/aminopterin/thymidine; Pi/NaCl, phosphate-
buffered saline; MDH, malate dehydrogenase.
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separated colonies were isolated and grown in DMEM/HAT.
These were obtained from primary cell lines GB20 and GB7d.
To obtain cells resistant to 5-bromodeoxyuridine (BrdUrd), cells
were grown in nonselective medium for one to two passages and
transferred to medium containing BrdUrd at 30,gg/ml. After
48 hr the culture was exposed to UV light for 1 hr. Pools of re-
sistant cells from individual flasks were maintained separately.
These cells were obtained from GB20 and GB7d and main-
tained in DMEM. All of the BrdUrd-resistant cells were sensi-
tive to HAT medium.
T-ag Assay. Cells were grown on glass coverslips until they
are 50-80% confluent. The medium was removed and after
washing with phosphate-buffered saline (Pi/NaCl) the cells
were fixed with 10% (vol/vol) formalin in Pi/NaCl for 10 min.
They were then treated with Ca2+- and Mg2+-free Pi/NaCl for
1 min, 50% (vol/vol) acetone for 3 min at -20°, 100% acetone
(-20°) for 5 min, 50% acetone for 3 min, and Pi/NaCl for 1
min. The coverslips were placed on top of moist filter paper in
a petri dish and 20 ,l of hamster antiserum to T-ag (Flow
Laboratories) diluted 1:10 was added. Following incubation
for 1 hr at 370 the coverslips were rinsed three times in Pi/NaCl.
After excess Pi/NaCl was drained, 20 ,l of fluorescein-labeled
goat antiserum to hamster IgG diluted 1:10 was added to each
coverslip and incubated at 370 for 1 hr. The coverslips were
rinsed in Pi/NaCl and H20 and mounted cell side down on
clean glass slides with Elvanol. The slides were allowed to dry
overnight and were observed with the aid of a Zeiss photomi-
croscope III equipped with an epiillumination system.
V-ag Assay. The methods for this assay are identical to T-ag
assay except the primary serum used was an anti-SV40 neu-
tralizing serum obtained from Flow Laboratories.
Viral DNA Assay. Total cellular DNA was obtained by the
methods described by Botchan et al. (19). DNA was hydrolyzed
with Bal I, an endonuclease isolated from Brevibacterium al-
bidum (22). For blotting the DNA was fractionated by agarose
electrophoresis. Following denaturation in situ the DNA was
transferred to a nitrocellulose filter by the method described
by Southern (23). SV40 DNA labeled to a high specific activity
by 32P was obtained by the methods of Maniatis et al. (24). The
conditions of hybridization and autoradiography have been
described (19).
Assay of Mitochondrial Malate Dehydrogenase. Rabbit
antiserum against purified human mitochondrial malate de-
hydrogenase (MDH-2) was obtained as described (25). Cell
extracts were tested against this antiserum by Ouchterlony
double diffusion. Details of this method have been described
by Shimizu et al. (26).
Enzyme Assays. Cell extracts were subjected to starch and
cellulose acetate gel electrophoreses and stained for the enzymes
listed in Table 1 by the methods described by Nichols and
Ruddle (27). These enzymes represent 14 different human
chromosomes.
Chromosome Analysis. Air-dried metaphase chromosome
preparations were made according to standard procedures. The
slides were stained with Atebrin (28), and chromosomes were
photographed on H & W VTE pan film (H & W, St. Johnsbury,
VT), using a Zeiss Axiomat microscope equipped with epi-
illumination optics. Chromosome analysis was conducted on
photographic prints.
RESULTS
In assigning SV40 integration to a human chromosome, ideally,
one should determine the number of integrated viral copies
present in the parental cell line and account for all of them in
the hybrid cell lines. In general and with GM637 in this case,
this is technically quite difficult because of the spontaneous
induction of viral DNA replication in human cells (there are
on the average 100 copies of SV40 DNA/cell in GM637; M. R.
Botchan, J. K. McDougall, and j. Sambrook, unpublished data).
To address ourselves to the question of the pattern of SV40 in-
tegration in GM637 as distinct from the free viral DNA, total
high molecular weight DNA from GM637 was separated from
free viral DNA by a two-step purification procedure (i) sucrose
gradient fractionation (Fig. 1A) followed by (Ui) an agarose
electrophoresis separation (Fig. 1B). The high molecular weight
DNA obtained from the agarose gels were then hydrolyzed with
Bal I, and SV40 DNA was detected by blot hybridization as
described in Materials and Methods. Fig. 1C shows the results
of this experiment: only one band containing SV40 DNA was
seen in the high molecular weight preparation from GM637.
This same band was detected in eight other hybrid cell DNA
preparations (Fig. 1C and Fig. 4). These results show that (i)
at the DNA level no rearrangements occurred upon fusion with
mouse B82 cells and selection of hybrid cells and (ii) the parent
line possessed only one integrated locus of SV40 DNA per
cell.
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FIG. 1. Comparison of integrated SV40 DNA in parental cell
line GM637 and two hybrid cell populations. Forty micrograms of
total high molecular weight GM637 cellular DNA was separated from
free SV40DNA in the preparation by centrifugation through a neutral
5-20% sucrose gradient, containing 10% (vol/vol) glycerol, 0.1 M NaCl,
0.01 M Tris-HCl at pH 8, and 0.001 M EDTA. The sample in 100 Al
was centrifuged through a 12-ml gradient in a Spinco SW 41 rotor at
41,000 rpm for 3 hr. Fractions were collected from a hole punched in
the bottom of the tube. The A M0 reading of each fraction is shown in
A. Fractions were pooled and assayed for SV40 DNA by blot hy-
bridization as described in Materials and Methods. The peak of free
SV40 form I DNA was seen in fractions 17,16, and 15. The high mo-
lecular weight cell DNA was further separated from free SV40 DNA
by electrophoresis through a 1.4% agarose gel. B shows the ethidium
bromide-stained pattern of the DNA from pooled fractions 1, 2, and
3. Roman numerals I and II point to the positions of free supercoiled
and nicked circular SV40 DNA in this gel. The DNA from fraction
I was eluted from the agarose gel and cleaved with the restriction
enzyme Bal. The fragments were separated by electrophoresis
through a 0.7% agarose gel, and the SV40-containing fragment in the
DNA was detected by blot hybridization. C shows the autoradiogra-
phic detection of this hybridization. Five micrograms of total cellular
DNA from hybrid cell clones GB2OE1 and GB20 were hydrolyzed with
the restriction enzyme Bal and run in parallel with GM637 fraction
1 DNA. The slot marked "SV40 reconstruction" contained 5 pg of
nicked circular SV40 DNA.
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Croce and colleagues, using three different SV40-trans-
formed cells as human parents in cell fusions, have reported
correlation of SV40 T-ag with human chromosome 7 in two cell
lines and with chromosome 17 in another. To determine if such
correlations could be made when GM637 was used as the
human parent, we performed the following experiments.
T-ag Expression. The parental mouse and human cells were
tested for T-ag by indirect immunofluorescence. Every cell in
the GM637 population was T-ag+: B82 cells were T-ag-.
Eighteen independently derived hybrid cell lines and 14 sec-
ondary lines derived from a single primary cell line were tested
for T-ag. Thirteen of the primary and all of the secondary cell
lines were T-ag+. Because of the HAT selection system all these
hybrid cells are expected to retain the gene for human thymi-
dine kinase (TK), which is on human chromosome 17. If the
T-ag expression is syntenic with human TK, all the hybrids
would be expected to be T-ag+. The lack of correlation between
T-ag and TK indicatedthat SV40 is not integrated in chromo-
some 17. To further test this possibility, we have isolated hybrid
cell lines resistant to BrdUrd at 30 gg/ml. Of the nine such cell
lines, derived from three independent primary hybrids, seven
were T-ag+. Because BrdUrd selects for cells that lack TK, these
cells have lost human TK and thus human chromosome 17. The
presence of T-ag in cells lacking chromosome 17 and its absence
in some of the cells containing chromosome 17 show that the
SV40 genome in these hybrid cells is not integrated in that
chromosome.
Marker Assays. Croce has reported (12) that chromosome
7 has an integration site for SV40. To test whether this chro-
mosome in GM637 carries an integrated SV40 genome, we have
tested several of our hybrid cell lines for MDH-2. The gene for
MDH-2 is known to be located on chromosome 7 (25, 29). In
addition, cell extracts from these hybrids were also used to
determine if any of 16 markers, representing 14 different
human chromosomes, were present. Results from the analyses
are presented in Fig. 2 and Table 1. None of the markers tested
correlated with T-ag. These results indicate that the SV40 T-ag
expression is asyntenic to markers located on chromosomes 1,
2, 5, 6, 7, 10, 11, 12, 14, 15, 17, 18, 19, 20, and X. Because we
have not tested for markers representing 3, 4, 8, 9, 13, 16, 21,
and 22, SV40 might be integrated in one or more of these
chromosomes.
Chromosome Analysis. Enzyme data alone cannot be used
to draw inferences about assignment of markers to specific
human chromosomes. Low levels of specific human chromo-
some presence might be reflected by either a positive or neg-
ative enzyme pattern. In order to determine which human
chromosome is necessary for T-ag expression, we undertook a
detailed cytological analysis of several of our primary and
secondary cell lines. GM637 is a heteroploid cell line, containing
a mean number of 79 chromosomes. At least one normal copy
I
Table 1. Correlations between SV40 T-ag expression
and human biochemical markers
Enzyme Chromosome Concordant Discordant
UGPP
MDH-1
Hex-B
ME-1
MDH-2
GOT
LDH-A
LDH-B
Pep-B
NP
MPI
Pep-A
GPI
ADA
G6PD
1
2
5
6
7
10
11
12
12
14
15
18
19
20
x
4
2
3
1
21
5
8
9
8
10
4
8
2
0
2
7
9
5
7
7
2
3
2
2
1
6
2
9
8
9
Concordant, T-ag and the human enzyme both present or absent;
UGPP, UDPglucose pyrophosphorylase; Hex-B, hexosaminidase B;
ME-1, malic enzyme 1; GOT, glutamic-oxaloacetic transaminase;
LDH, lactate dehydrogenase; Pep, peptidase; NP, nucleoside phos-
phorylase; MPI, mannose phosphate isomerase; GPI, glucose phos-
phate isomerase; ADA, adenosine deaminase; G6PD, glucose-6-
phosphate dehydrogenase.
of each of the chromosomes was present in most cells of this cell
line (Fig. 3). Chromosome analysis of hybrid cell lines was
conducted within one to two passages of T-ag and enzyme as-
says. The results of this analysis are presented in Table 2. The
only chromosome that was present in all T-ag+ cell hybrids was
chromosome 8, with one exception. GB7dl, a BrdUrd-resistant
subclone of GB7d, was T-ag+ but did not contain an identifiable
chromosome 8. Possible reasons for this discrepancy will be
discussed later. Hybrids that did not contain chromosome 8
were T-ag-. No correlations could be made between T-ag and
any other intact or marker human chromosome. On the basis
of these results we conclude that human chromosome 8 is
necessary for T-ag expression in B82 X GM637 hybrids. The
implication of this observation is that in GM637 this is the only
human chromosome carrying an integrated SV40 genome.
DNA Analysis. Though it is reasonable to assume that
chromosome 8 carries the integrated SV40 sequences, it would
be useful to demonstrate it directly. The cytogenetic data
predict that all hybrids that are T-ag+ contain SV40 sequences
integrated into chromosome 8.
.5
37
FIG. 2. Double immunodiffusion analysis of human mitochon-
drial NAD-linked malate dehydrogenase. The central wells contained
8 gl of the rabbit antiserum against human mitochondrial MDH that
had been absorbed with mouse A9 cell extract. The numbered pe-
ripheral wells contained 8 ,l each of the following test samples: 1,
human HeLa cell extract; 2, human-mouse hybrid GB7d, which does
not carry human chromosome 7; 3, mouse B82; 4, human-mouse hy-
brid GB1Oa, which carries human chromosome 7; 5, human HeLa; 6,
human-mouse hybrid GB2OA1, which carries human chromosome
7; 7, mouse A9; and 8, human-mouse hybrid GB2OG2 (chromosome
data not available). FIG. 3. GM637 karyotype; bottom line, marker chromosomes.
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Table 2. T-ag expression and human chromosomal constitution of hybrid cell lines
Cell No. of Viral Chromosome
line cells T-ag DNA 1 2 3 4 5 6 7 8 9 10 11 12 X 13 14 15 16 17 18 19 20 21 22
GB7d 32 + NT + + + + + + ++
GB10a 24 - NT + + + + + + +
GB20 26 + + + + + + + + + + + + + + +
GB35c 17 - - + + + + +
GB40a 17 - - + + + + + + + + + +
GB40c 29 + NT + + + + + + + + + + +
GB42 25 + NT + + + + +
GB44b 20 + + + + + + + + + + + + + + + + +
GB20A1 33 + NT + + + *+ + + + + + + +
GB20A2 31 + NT + + + + + + + + + + + +
GB2OD1 22 + NT + + + + + + + + + + + + +
GB2OE2 26 + NT + + + + + + + + + +
GB20B1 17 + NT + + + + + + + + + + + + ++
GB20C1 14 + + + + + + + + + + + + +
GB2OE1 8 + + + + + + + + + + + + + + +
GB20F1 20 + NT + + + + + + + + + + + + +
GB2OG1 26 + + + + + + + + + + + + + + +
GB20H1 16 + NT + + + + + + + + + + + + + +
GB202t 22 + + + + + + + + + + +
GB7d1t 27 + NT + + +
Chromosomes present at a frequency of 10% or more are considered positive. NT, not tested. * Chromosome 7 present in 9% of the cells. t These
two cell lines are BrdUrd resistant.
In order to determine that the SV40 DNA is covalently linked
and that the pattern of integration in all T-ag+ hybrids is
identical, we have tested for the presence of SV40 sequences
by the method of Botchan et al. (19) and Ketner and Kelly (20).
Ten cell lines, five of which are primary and five secondary
clones were tested. Representative results of these assays are
presented in Fig. 4. The restriction enzyme used in this analysis
does not cleave within the SV40 genome. Thus the integrated
viral genome is expected to migrate to a position representing
a higher molecular weight than SV40. This expectation is re-
alized. All hybrids which showed a band of DNA which hy-
bridized with labeled SV40 DNA were T-ag+. T-ag negative
hybrids showed no bands. All hybrids which are T-ag positive
had a single band of DNA which hybridized with SV40 DNA
and this migrated to the same position in all hybrids. These
results indicate that all hybrids which are T-ag+ have viral se-
quences integrated in the human genome and that the inte-
gration sites, in terms of flanldng host sequences as defined by
the cleavage by Bal I enzyme, are similar, if not identical. The
presence of this inserted viral DNA correlated with the presence
of chromosome 8.
V-ag. Human cells are semipermissive for SV40 replication,
and tests for V-ag in GM637 showed that a small proportion
(-1%) of the cells are V-ag+. To determine if there is a chro-
mosomal basis for the expression of V-ag, we studied its ex-
pression in cell hybrids. All hybrids that are T-ag- are also V-
ag-. Most of the hybrids that are T-ag+ are also V-ag-. In a few
hybrids V-ag was expressed by a small proportion of the cells.
Further investigations are necessary to determine the genetic
basis for SV40 V-ag expression in these cell hybrids.
DISCUSSION
We have shown that, in a series of hybrids between B82 and
GM637, SV40 T-ag expression is retained in some and lost in
other hybrids. Chromosome analysis revealed that all hybrid
cell lines that contained chromosome 8 were T-ag+. All hybrid
cell lines that did not retain an identifiable chromosome 8, with
one exception, were T-ag-. No correlations could be made
between T-ag expression and any other human chromosome.
We conclude that chromosome 8 in GM637 carries an inte-
grated SV40 viral genome. The exception to the concordant
expression of T-ag and chromosome 8 is the cell line GB7d1.
Detailed examination of its chromosomal composition revealed
a low level of human chromosome 8 and high frequencies of
chromosome 12 and a modified chromosome 4. Other cell lines
that contained these three chromosomes individually or in
combinations were T-ag- if chromosome 8 was absent. Thus
the most likely explanation for the exceptional behavior of
GB7dl is that it contains a modified or rearranged chromosome
8 carrying the SV40 genome.
We have established that SV40 has integrated at a single site
in GM637 by two independent methods. First, we have shown
that the high molecular weight DNA from GM637 shows a
single band of DNA containing the SV40 genome after a blot
hybridization experiment. All of the hybrid cell lines that
contained SV40 DNA contained it in the region defined by the
blots. Studies with other restriction enzymes, Pvu II and EcoRI,
are consistent with this conclusion (data not shown). The second
method is to examine a series of unreduced hybrids, among
which collectively all human chromosomes are represented,
and show that one specific chromosome correlates with SV40
gene expression. In this case the presence of human chromo-
some 8 correlates with SV40 T-ag expression.
Among the hybrids we have studied, all that are viral DNA
positive are also T-ag+ and contain a single copy of viral DNA.
Thus, our DNA determinations support assignment of the SV40
integration site to a single chromosome by cytogenetic methods.
These results also indicate that the viral genome does not excise
and reintegrate into the mouse or the other parts of the human
genome.
Croce and colleagues (12-18) have reported SV40 integration
sites in human chromosomes 7 and 17. We failed to find cor-
relations between these chromosomes and SV40 T-ag expression
or DNA in our hybrids. The lack of correlation between SV40
DNA or T-ag and either MDH-2 and TK or chromosomes 7 and
17 rules out assignment of SV40 integration to either of these
chromosomes in GM637. When our evidence and that pre-
sented by Croce and colleagues is taken together, it seems clear
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FIG. 4. Detection of integrated SV40 DNA sequences in hybrid
cell genomes. Five micrograms of various cell DNAs were hydrolyzed
with the Bal I restriction enzyme (22). After the incubation period
the resultant fragments were separated by electrophoresis through
a 0.7% agarose gel at 1.5 V/cm for 16 hr. After denaturation and
transfer to nitrocellulose sheets, DNA on the sheets was hybridized
with nick-translated SV40 DNA as described (19), except that the
filter was pretreated in ten times concentrated Denhardt's solution,
and the final hybridization solution had a final volume of 10 ml and
contained 1 ,ug of radioactive SV40 DNA. The slot labeled "Rec"
(reconstruction) contains 1 pg of adenovirus 2 DNA and 5 pg of SV40
DNA. This amount of SV40 DNA is equivalent to the mass of one viral
genome in 5 jg of total cellular DNA, if each cellular genome contained
one copy of the viral DNA. The variabilities in intensities of the bands
across the gel were reproducible, and some cell lines clearly have
slightly less viral DNA than others. This reflects the heterogeneity
of the number of chromosomes 8 seen in the various hybrid popula-
tions. (Right) Autoradiogram of the nitrocellulose sheet after hy-
bridization. (Left) Ethidium bromide stain pattern of the recon-
structiontslotshowing the Bal I fragments of adenovirus 2 that were
used as markers to calculate the molecular weight of the cell Bal I
fragment that contains the SV40 genome and of the stained pattern
of total hybrid cell DNA after cleavage with Bal I. Form II SV40 is
detected in the reconstruction and a cell fragment of molecular weight
approximately 5.5 X 106 in all the T-ag+ hybrid cell DNAs. The cell
samples were: 1, GB201; 2, GB202; 3, GB44b; 4, GB20C1; 5, GB40a;
6, GB34mp; 7, GB35c; 8, GB20E1; 9, GB20; and 10, GB20G1.
that SV40 can integrate at one of several sites in the human
genome and that it is not chromosome specific. The presence
of multiple sites for integration of SV40 in rodent cells has been
shown (19, 20). All of these data indicate that the SV40 gene
product(s) that is responsible for maintenance of transformation
can be expressed from multiple chromosomal sites. One ques-
tion left unanswered is whether the integration sites are multiple
but unique or truly randQm.
The data presented in this paper and others (12-18) must be
viewed in light of different levels of analysis employed. It is
possible that recombination systems available for SV40 inte-
gration may require that only a small number of chromosomes
are accessible for these events, while at the same time restraints
imposed for insertion at the DNA sequence level may allow far
more promiscuous recombination. Available evidence indicates
that there is no chromosome or DNA sequence specificity in
integration of SV40 genome into mammalian genomes.
Human cells are semipermissive for replication of SV40 (30).
A small proportion of cells in a transformed line can produce
viable SV40 particles. In GM637 about 1% of cells are V-ag+.
The viral DNA that is present inside these cells might be able
to reintegrate at other potential sites such as the ones on 7 and
17, or if virus is released it might be able to superinfect other
cells in the population and integrate at other available sites.
However, our observations, both genetic and biochemical, in-
dicate that all hybrids tested, and as such GM637, contain the
virus at a single site. A simple explanation can be offered for
this paradox. The cells that produce viable virus lyse, elimi-
nating any traces of reintegration within them, and the virus
that is released will be at too low a concentration to effectively
superinfect cells. Alternatively, transformed cells that are sur-
vivors of initial viral infection may be resistant to viral ab-
sorption.
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